ARCHIVES

In Brief: Ingell Vows To Broaden Indirect Cost Inquiry; Gallo, Fauci Make ‘Most Prolific Scientist’ List

This article is from The Cancer Letter archive.

Vol. 18 No. 06 | February 7, 1992

Download PDF Visit The Full Archive

Related Articles

Tobacco Control Bill Requires Stronger Warnings

August 10, 1990

Turmoil in Texas: AVEO, DePinho Joined at the Hip (Pocket)

May 8, 2013

IOM Panel: NCI Clinical Trials Groups At “Breaking Point,” More Funds Needed.

April 16, 2010

In Brief: ONS, ASCO AACR Meetings Open In St. Louis Next Week; Bristol-Myers Adds Farber, McArdle Grants

April 16, 1982

Progression-free survival as a primary endpoint for drug approval requires prospective planning, FDA’s Pazdur says.

May 7, 2004

Reinventing NCI: Rimer Says Report Consistent with Her Goals For DCCPS

October 17, 1997